CD

(redirected from Orange Book)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

CD (1)


CD (2)

The two-character ISO 3166 country code for CONGO, THE DEMOCRATIC REPUBLIC OF.

Certificate of Deposit

A deposit at a bank or other financial institution that has a fixed return (usually via an interest rate) and a set maturity. The depositor does not have access to the funds in a certificate of deposit until maturity; in exchange, he/she is usually entitled to a higher interest rate. CDs are insured by the FDIC up to a certain amount and as such are a way to increase return for no extra risk. See also: Demand deposit, Real estate certificate of deposit, Negotiable certificate of deposit.

CD

Certificate of deposit (CD).

CDs are time deposits. When you purchase a CD from a bank, up to $100,000 is insured by the Federal Deposit Insurance Corporation (FDIC).

You generally earn compound interest at a fixed rate, which is determined by the current interest rate and the CD's term, which can range from a week to five years.

However, rates can vary significantly from bank to bank. You usually face a penalty if you withdraw funds before your CD matures, often equal to the interest that has accrued up to the time you make the withdrawal.

CD

See certificate of deposit.
References in periodicals archive ?
What is more, if the originator firm lists another patent in the Orange Book during the 30 months' stay, then it is entitled to file a new infringement lawsuit, automatically instigating a new 30-month stay and further extending its monopoly.
Access Orange Book data to track latest product patent and exclusivity
Patent 4,743,450 (the '450 patent) listed in FDA's Orange Book.
In connection with the FDA's acceptance for filing of the ZEGERID Capsules NDA, Santarus provided notice to the NDA holder for Prilosec(R) delayed-release omeprazole capsules and related patent holders that ZEGERID Capsules 40 mg and 20 mg do not infringe the patents listed in the Orange Book for Prilosec or that those patents are invalid.
The Company intends to also list the '102 Patent in the Orange Book following submission of the necessary information to the FDA.
If the NDA is accepted for filing by the FDA, Santarus will provide notice to the NDA holder for Prilosec(R) delayed-release omeprazole capsules and related patent holders that ZEGERID Chewable Tablets 40 mg and 20 mg do not infringe the patents listed in the Orange Book for Prilosec or that those patents are invalid.
The ANDA contained a certification that the patents listed in the Orange Book for mirtazapine orally disintegrating tablets were invalid or would not be infringed by Barr's product.
Teva received FDA approval to market a generic capsule product following summary judgment on all Orange Book patents, but only after Abbott had ceased sales of its capsule products and had taken steps to frustrate Teva's ability to fully commercialize that product as a generic.
The '819 Patent was the only patent listed in the FDA's Orange Book at the time that Barr filed its ANDA in November 2002.
Floxin(R) is covered by a US patent listed in the Orange Book and currently subject to a litigation between Daiichi and Bausch & Lomb, which was first to file an ANDA on this product.
The action follows the FDA's release on 12 June of new regulations concerning, among other matters, the listing of patents in the Orange Book.
If the NDA is accepted for filing by the FDA, Santarus will provide notice to the NDA holder for Prilosec(R) delayed-release omeprazole capsules and related patent holders that ZEGERID Capsules 40 mg and 20 mg do not infringe the patents listed in the Orange Book for Prilosec or that those patents are invalid.